Unaudited Condensed Statement of Cash Flows	3 Months Ended
	Mar. 31, 2021 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (5,184,207)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative warrant liabilities	3,392,750
Transaction costs	1,406,506
Income from investments held in Trust Account	(7,058)
Changes in operating assets and liabilities:
Prepaid expenses	(1,317,250)
Accounts payable	18,194
Accrued expenses	48,306
Franchise tax payable	47,660
Net cash used in operating activities	(1,595,099)
Cash Flows from Investing Activities
Cash deposited in Trust Account	(862,500,000)
Net cash used in investing activities	(862,500,000)
Cash Flows from Financing Activities:
Proceeds from note payable to related party	2,000
Repayment of note payable to related party	(266,099)
Proceeds received from initial public offering, gross	862,500,000
Proceeds from private placement	19,250,000
Offering costs paid	(17,369,609)
Net cash provided by financing activities	864,116,292
Net change in cash	21,193
Cash - beginning of the period	47,090
Cash - end of the period	68,283
Supplemental disclosure of noncash financing activities:
Offering costs included in accounts payable	250,000
Offering costs included in accrued expenses	372,369
Offering costs paid by related party under promissory note	94,099
Deferred underwriting commissions	30,187,500
Reversal of offering costs included in accounts payable in prior year	113,386
Derivative warrant liabilities in connection with initial public offering and private placement	(39,511,970)
Initial value of common stock subject to possible redemption	788,774,130
Change in value of common stock subject to possible redemption	$ (3,737,040)